Hanall Biopharma (009420) — Financial Flexibility Index
Hanall Biopharma (009420) has a Financial Flexibility Index of 0.24x as of September 2025. Free cash flow of ₩10.61 Billion (operating CF ₩7.34 Billion minus capex ₩3.27 Billion) represents 0% of total liabilities (₩44.17 Billion). Check Hanall Biopharma (009420) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hanall Biopharma Financial Flexibility Index (2011–2024)
Historical Financial Flexibility Index trend for Hanall Biopharma across 14 annual periods. For the full cash flow conversion analysis, see Hanall Biopharma operating cash flow efficiency.
Annual Financial Flexibility Index for Hanall Biopharma (2011–2024)
Year-by-year free cash flow to debt coverage for Hanall Biopharma. Explore 009420 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.73x | ₩32.43 Billion | ₩9.36 Billion | ₩44.53 Billion | ▲ +0.4% |
| 2023 | 0.73x | ₩38.84 Billion | ₩29.64 Billion | ₩53.53 Billion | ▲ +17.0% |
| 2022 | 0.62x | ₩28.03 Billion | ₩25.20 Billion | ₩45.19 Billion | ▲ +298.5% |
| 2021 | 0.16x | ₩5.45 Billion | ₩839.87 Million | ₩34.99 Billion | ▲ +73.2% |
| 2020 | 0.09x | ₩3.49 Billion | ₩929.29 Million | ₩38.86 Billion | ▼ -79.7% |
| 2019 | 0.44x | ₩22.61 Billion | ₩20.49 Billion | ₩50.97 Billion | ▲ +1972.5% |
| 2018 | -0.02x | ₩-1.08 Billion | ₩-2.99 Billion | ₩45.39 Billion | ▼ -103.1% |
| 2017 | 0.76x | ₩43.87 Billion | ₩42.14 Billion | ₩57.50 Billion | ▲ +94.7% |
| 2016 | 0.39x | ₩7.98 Billion | ₩3.95 Billion | ₩20.37 Billion | ▲ +461.3% |
| 2015 | 0.07x | ₩1.53 Billion | ₩-454.02 Million | ₩21.91 Billion | ▲ +228.4% |
| 2014 | -0.05x | ₩-2.25 Billion | ₩-3.52 Billion | ₩41.36 Billion | ▲ +37.1% |
| 2013 | -0.09x | ₩-3.30 Billion | ₩-7.78 Billion | ₩38.23 Billion | ▼ -190.0% |
| 2012 | 0.10x | ₩4.38 Billion | ₩2.20 Billion | ₩45.60 Billion | ▼ -32.9% |
| 2011 | 0.14x | ₩7.84 Billion | ₩7.41 Billion | ₩54.75 Billion | — |